Min-Ji Charng

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Monoclonal Antibody

Clinical Evaluation

Cardiovascular Risk Factors

Top Venues

Therapeutics and clinical risk management

Arteriosclerosis, thrombosis, and vascular biology

Taipei Veterans General Hospital

Baylor College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Taipei Veterans General Hospital Sep 01 1983

Taiwan

Professor :: Medicine

Education History

Baylor College of Medicine Jul 01 1997

United States

PHD

Publications

Albert Wiegman, Susanne Greber-Platzer, Shazia Ali, M Doortje Reijman, Eliot A Brinton, Min-Ji Charng, Shubha Srinivasan, Carissa M Baker-Smith, Seth J Baum, Julie A Brothers, Jacob Hartz, Patrick M Moriarty, Jeanne Mendell, Sébastien Bihorel, Poulabi Banerjee, Richard T George, Boaz Hirshberg, Robert Pordy
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia. Circulation (2023)
Éric Bruckert, Sonia Caprio, Albert Wiegman, Min-Ji Charng, Cézar A Zárate-Morales, Marie T Baccara-Dinet, Garen Manvelian, Anne Ourliac, Michel Scemama, Stephen R Daniels
Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study. Arteriosclerosis, thrombosis, and vascular biology 42 (12) (2022)
Chin-Chou Huang, Min-Ji Charng
Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients. Therapeutics and clinical risk management 15 (2019)